MONJUVI (tafasitamab-cxix) 200 mg for injection, targeted immunotherapy for intravenous use in R/R DLBCL and recommended by NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Please see the full Prescribing Information, including indication and Important Safety Information.
Domain | monjuvihcp.com |
---|---|
Homepage URL | https://www.monjuvihcp.com |
Sprache | englisch |